The Pause Technologies Inc. Wins First Place in the HITLAB x Versalie™ Innovation Challenge

[Phoenix, AZ] — November 22nd, 2024 — The Pause Technologies Inc., the company behind the innovative menopause management platform thePause™, has been awarded first place in the prestigious HITLAB x Versalie™ Innovation Challenge. Selected from hundreds of innovative submissions, this accolade highlights thePause™’s mission to make menopause support accessible and personalized through their digital health platform. The company will receive a $25,000 prize to continue advancing its impactful work.Continue reading

AdvaMed Welcomes Bipartisan Senate Bill to Expedite Medicare Coverage of Breakthrough Medical Technologies, Diagnostic Tests

Washington, D.C. – AdvaMed, the Medtech Association, today welcomed introduction in the U.S. Senate of bipartisan legislation to expedite Medicare coverage of FDA-“breakthrough”-designated medical technologies and diagnostic tests. The legislation, the Ensuring Patient Access to Critical Breakthrough Products Act, introduced by Sen. Todd Young (R-IN) and Sen. Alex Padilla (D-CA), is similar to H.R. 1691, which the U.S. House of Representatives Ways and Means Committee passed on a bipartisan basis in June.  Continue reading